Treatment of Neuroendocrine Neoplasms with Radiolabeled Peptides—Where Are We Now

SIMPLE SUMMARY: Neuroendocrine neoplasms (NENs) are a rare and diverse group of malignancies which are rising in incidence. Several treatments have been devised for unresectable or metastatic tumors, including peptide receptor radionuclide therapy (PRRT). PRRT specifically targets cells that express...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Mitesh, Al-Nahhas, Adil, Khan, Sairah R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833798/
https://www.ncbi.nlm.nih.gov/pubmed/35159027
http://dx.doi.org/10.3390/cancers14030761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833798/
https://www.ncbi.nlm.nih.gov/pubmed/35159027
http://dx.doi.org/10.3390/cancers14030761

Ejemplares similares